A service provided by the BC Centre for Disease Control



Home / Resources / STI Updates (Blog) / Program updates / New Web Tool – Hepatitis C: The Basics!

New Web Tool – Hepatitis C: The Basics!

Looking for one stop, easy-to-understand information about hepatitis C for your patients?   A free online learning module, Hepatitis C: The Basics, is now available.

Hepatitis C: The Basics is a publicly-available course, hosted on the Provincial Health Services Authority (PHSA) Learning Hub, and is aimed at the estimated 70,000 to 80,000 British Columbians affected by hepatitis C.

The module is narrated, has minimal text, and includes videos, quizzes and downloadable materials. This interactive, national resource is valuable for anyone interested in learning more about hepatitis C.

The go-at-your-own-pace module includes topics such as:

  • how hepatitis C is spread
  • how to get tested
  • living with hepatitis C
  • treatment and post treatment

To access the course:

  1. Go to https://learninghub.phsa.ca/Courses/5935/hepatitis-c-the-basics
  2. On the Learning Hub page that opens, click the “START COURSE” button

This course is available to anyone. You do not need to be a PHSA employee or have a Learning Hub account to view it. Please note that the module requires the Flash plugin and will not run on iOS devices (iPhone, iPad, iPad 2).

Hepatitis C: The Basics, and its associated resources, were developed through the University of British Columbia “Attendance for Hepatitis C Care” research project led by Dr. Gail Butt.  She and her team worked with many people infected with hepatitis C, as well as with health and social service providers across Canada, to learn why people with hepatitis C sometimes don’t go for care. A number of resources have been developed through the study to encourage engagement with testing, care and treatment. 

Getting tested is especially important for baby-boomers, who represent about two-thirds of those infected.

In the next two to five years, treatments are expected to be able to cure greater than 90 per cent of infections with significantly fewer side effects than with current therapies.

This project was supported by the BC Centre for Disease Control and the University of British Columbia, and funded by the Public Health Agency of Canada.